VTRS - Viatris Inc logo

Viatris Inc

VTRS

Viatris Inc. develops, manufactures, and distributes prescription brand drugs, generics, complex generics, and biosimilars across therapeutic areas, serving patients through retail pharmacies, wholesalers, institutions, and direct providers globally.

โš•๏ธ Healthcare NASDAQ Listed 2020 $ USD
$1,000 invested 30 years ago โ†’$3,160today

Score Overview

1 Year
Score
Net Growth88.32%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth3.06%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score3.9
Net Growth67.64%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth-17.61%
Rev Trend20%
Revenue Consistencyโ€”
All Time
Score
Net Growth38.69%
Net Trend33%
Net Income Consistency
Rev Growth23.37%
Rev Trend33%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Viatris Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 5 years of fundamentals. VTRS does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-01
$ 17.46โ€”
1 Year2025-10-01
$ 9.7479.18%
5 Years2021-10-01
$ 11.0258.43%
10 Years2016-09-30
$ 30.44-42.65%
20 Years2006-09-29
$ 15.939.60%
30 Years1996-10-01
$ 5.53216.01%
All Time2020-11-16
$ 12.6737.85%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 14.73B-$ 410M$ 886M
2025$ 14.29B-$ 3.51B$ 1.45B
2024$ 14.73B-$ 634M$ 1.08B
2023$ 15.42B$ 54M$ 1.18B
2022$ 16.26B$ 2.07B$ 1.47B
2021$ 17.88B-$ 1.26B$ 935M
IPO2020$ 11.94B-$ 669M$ 1.04B
VTRS - Viatris Inc logo

Viatris Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 11.94B to $ 14.29B and net income went from -$ 669M to -$ 3.51B. Revenue increased in 1 of those 5 years; net income in 2.

Viatris Inc currently holds a 5-year HDB Score of 3.9 out of 10. How the HDB Score is calculated.

Membership

Explore VTRS with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,813 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies